Remove Digital Health Remove Drug Development Remove Health Data
article thumbnail

Koneksa Announces Study with New York Proton Center to Collect Patient-Generated Health Data During Proton Radiotherapy in Lung Cancer

Digital Health Global

This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., The study, led by principal investigator Nitin Ohri, M.D., The study, led by principal investigator Nitin Ohri, M.D., Chief Medical Officer, Koneksa. “By

article thumbnail

Digital Healthcare Transformation: Improving Patient Experience and Outcomes

Digital Health Global

Enhancing outcomes for patients with the implementation of digital technologies, such as artificial intelligence (AI) and big data analysis, empowers healthcare professionals to make better-informed decisions. Artificial Intelligence is utilized in various areas of healthcare, ranging from drug development to medical image analysis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital Health v HealthTech: What is the difference?

Lloyd Price

Exec Summary: Digital Health is a subset of Healthtech. Digital Health focuses on the individual patient, while Healthtech focuses on the entire healthcare ecosystem. Wearable devices: These are devices that are worn on the body and can track health data such as heart rate, sleep, and activity levels.

article thumbnail

Self-sovereign identity (SSI) - the future of Health Data?

Lloyd Price

Exec Summary: Self-sovereign identity (SSI) holds immense potential to revolutionize the future of health data, empowering individuals to take control of their information and fostering a more secure, transparent, and patient-centric healthcare ecosystem. Overall, SSI presents a transformative opportunity for the future of health data.

article thumbnail

Catawba Research Expands Scientific Advisory Board With Renowned Experts in Immunology and Dermatology

Digital Health Global

Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia.

article thumbnail

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.